Implantable defibrillator

DEVICE3 trials

Sponsors

Medtronic Cardiac Rhythm and Heart Failure, Boston Scientific Corporation

Conditions

Heart DiseaseSudden Cardiac DeathVentricular FibrillationVentricular FlutterVentricular Tachycardia

Phase 4

Avoid DeliVering TherApies for Non-sustained Arrhythmias in ICD PatiEnts III

CompletedNCT00617175

Medtronic Cardiac Rhythm and Heart FailureHeart Disease

Start: 2008-03-31End: 2012-02-29Updated: 2025-07-02

Unknown Phase

SAFEty of Two Strategies of ICD Management at Implantation

CompletedNCT00661037

Boston Scientific CorporationSudden Cardiac Death, Ventricular Fibrillation, Ventricular Flutter

Start: 2008-03-31End: 2011-09-30Updated: 2017-07-21

Shockless Implant Evaluation

CompletedNCT00800384

Boston Scientific CorporationVentricular Fibrillation, Ventricular Tachycardia

Start: 2009-01-31End: 2014-05-31Updated: 2018-03-30

Related Papers

Determinants of worse prognosis in patients with cardiac resynchronization therapy defibrillators. Are ventricular arrhythmias an adjunctive risk factor?

Journal of Cardiovascular Medicine2021-08-131 citations

Sex differences in implantable cardiac defibrillator therapy according to arrhythmia detection times

Heart2019-12-115 citations

Atrioventricular Junction Ablation in Patients with Atrial Fibrillation Treated with Cardiac Resynchronization Therapy: Positive Impact on Ventricular Arrhythmias, Implantable Cardioverter-Defibrillator Therapies and Hospitalizations

European Journal of Heart Failure2017-12-1849 citations

Implantable cardioverter-defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudy.

2017-11-2015 citations

Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III Trial.

2017-05-3122 citations

Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).

2015-02-23160 citations

No Defibrillation Testing Best for ICD Implantation

MD Conference Express2014-07-01

Efficacy of Long Detection Interval Implantable Cardioverter-Defibrillator Settings in Secondary Prevention Population

Circulation2014-05-1773 citations

Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.

2013-05-01292 citations

Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant.

2012-08-0152 citations